Select for export Psychedelics: Science sabotaged by Social Media. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.neuropharm.2023.109426 PubMed 36693562 Copy citation Copy BibTeX Unknown journal 2023-01-20 Sellers EM, Romach MK. Europe PMC Published psilocybin Safety Other More
Select for export 5-HT2ARs Mediate Therapeutic Behavioral Effects of Psychedelic Tryptamines Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/acschemneuro.2c00718 PubMed 36630260 Copy citation Copy BibTeX ACS Chemical Neuroscience 2023-01-10 Lindsay P. Cameron, Seona D. Patel, Maxemiliano V. Vargas, Eden V. Barragan, Hannah N. Saeger, Hunter T. Warren OpenAlex Published psilocybin PharmacologyReceptor PharmacologySafety Other More
Select for export Psilocin suppresses methamphetamine-induced hyperlocomotion and acquisition of conditioned place preference via D2R-mediated ERK signaling Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1111/cns.14054 PubMed 36627756 Copy citation Copy BibTeX CNS Neuroscience & Therapeutics 2023-01-09 Jing Wang, Min Liang, Qing Shang, Hongyan Qian, Ran An, Hua Liu OpenAlex Published psilocybinpsilocin PharmacologyMechanism of ActionReceptor Pharmacology Animal Study More
Select for export Acute neurovascular effects of psilocybin administration in healthy humans: Implications for cerebral blood flow measurements using arterial spin labelling No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2023.102665 Copy citation Copy BibTeX Neuroscience Applied 2022-12-31 Klaus Richter Larsen, Ulrich Lindberg, Brice Ozenne, Drummond E-Wen McCulloch, Sophia Armand, M. Madsen OpenAlex Published psilocybin PharmacologyReceptor Pharmacology Other More
Select for export Psilocybin rescues depressive phenotype and modulates serotonin-2A and glucocorticoid receptor mRNA expression in brain cortex of a stress animal model No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2023.102452 Copy citation Copy BibTeX Neuroscience Applied 2022-12-31 Ines Erkizia-Santamaría, Guadalupe Rivero, Igor Horrillo, J. Javier Meana, Jorge E. Ortega OpenAlex Published psilocybin DepressionPharmacologyReceptor Pharmacology Other More
Select for export The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a long-term observational follow-up study No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2023.102906 Copy citation Copy BibTeX Neuroscience Applied 2022-12-31 Guy M. Goodwin, Lindsey Marwood, S. Mistry, Anna Nowakowska, Zainib Shabir, H. Clifton Simmons OpenAlex Published psilocybin DepressionObservational StudyTreatment-Resistant Depression Observational Study More
Select for export Effect of co-administration of low doses of psilocybin and mGluR2/3 antagonist LY341495 in chronic restraint stress model of depression No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2023.102939 Copy citation Copy BibTeX Neuroscience Applied 2022-12-31 Agata Machaczka, Jane Turek, Dorota Bederska-Łojewska, Bartłomiej Pochwat, Łukasz Gąsior, Bernadeta Szewczyk OpenAlex Published psilocybin DepressionReceptor Pharmacology Other More
Select for export Behavioral effects of a 14-day repeated treatment with psilocybin at a low non-psychedelic dose: a preliminary study in C57BL/6J mice No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2023.103378 Copy citation Copy BibTeX Neuroscience Applied 2022-12-31 Sofia Nasini, Martina Colognesi, Sara Tidei, Sara De Martin, Marco Banzato, Andrea Mattarei OpenAlex Published psilocybin PharmacologyReceptor PharmacologyAnimal Study Animal Study More
Select for export Withdrawal of antidepressants does not impact the efficacy of COMP360 psilocybin therapy: results from a phase IIb randomised controlled trial No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2023.103487 Copy citation Copy BibTeX Neuroscience Applied 2022-12-31 Guy M. Goodwin, Megan Croal, J. Chai-Rees, Lindsey Marwood, S. Mistry, Anna Nowakowska OpenAlex Published psilocybin Clinical TrialRandomized Controlled Trial Randomized Controlled Trial More
Select for export Change in whole blood BDNF after escitalopram or psilocybin intervention in patients with depression and healthy controls No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2023.103646 Copy citation Copy BibTeX Neuroscience Applied 2022-12-31 Miriam L. Navarro, Alberte Wollesen Breum, Annette Johansen, Brice Ozenne, Vibe G. Frøkjær, Gitte M. Knudsen OpenAlex Published psilocybin DepressionAnxietyPersonality Change Other More
Select for export A multi-metric evaluation of psilocybin effects on functional brain entropy in healthy volunteers No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2023.103723 Copy citation Copy BibTeX Neuroscience Applied 2022-12-31 Drummond E-Wen McCulloch, Anders Smærup Olsen, Dea Siggaard Stenbæk, Sophia Armand, M. Madsen, Gitte M. Knudsen OpenAlex Published psilocybin Healthy Volunteers Other More
Select for export Investigating changes in EEG entropy rate in response to psilocybin - a comparison of lempel ziv and state-space entropy rate measures No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2023.103667 Copy citation Copy BibTeX Neuroscience Applied 2022-12-31 M. Nikolič, P. Mediano, Tom Froese, Tomáš Páleníček OpenAlex Published psilocybin Brain Imaging Other More
Select for export Italian psychedelic therapies of the past century: An historical overview Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/20503245231179687 Copy citation Copy BibTeX Drug Science Policy and Law 2022-12-31 Adriana D’Arienzo, Giorgio Samorini OpenAlex Published psilocybin DepressionReceptor Pharmacology Other More
Select for export Therapeutic mechanism of psilocybin in the treatment of depression and other psychiatric disorders. No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2023.101067 Copy citation Copy BibTeX Neuroscience Applied 2022-12-31 O. Shahar, A. Botvinik, T. Lifschytz, B. Lerer OpenAlex Published psilocybin Depression Other More
Select for export Ego Birth: Measure 109, The NMHA, and Forward Movement in the Nascent Psilocybin Industry No abstract availability was recorded for this entry. Details DOI 10.2139/ssrn.4459584 Copy citation Copy BibTeX SSRN Electronic Journal 2022-12-31 Andrew M. Robie OpenAlex Published psilocybin General Other More
Select for export Psilocybin as a treatment for anorexia nervosa: 6-week and 3-month follow-up results No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2023.102878 Copy citation Copy BibTeX Neuroscience Applied 2022-12-31 Hannah Douglass, Merle Spriggs, Kate Godfrey, Jennifer L. Danby, Francisco Magalhães, Kirsty L. Alderton OpenAlex Published psilocybin Eating Disorders Other More
Select for export A roadmap for psychedelic pharmacy in Canada: A proposed policy and operations approach for controlled access to select psychedelics for treatment of mental illness Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/20503245231170340 Copy citation Copy BibTeX Drug Science Policy and Law 2022-12-31 Jaden Brandt OpenAlex Published psilocybin Toxicity Other More
Select for export Case report: Prolonged amelioration of mild red-green color vision deficiency following psilocybin mushroom use Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/20503245231172536 Copy citation Copy BibTeX Drug Science Policy and Law 2022-12-31 Brian S. Barnett, Noah Wiles Sweat, Peter S. Hendricks OpenAlex Published psilocybin AddictionMechanism of ActionCase Report Case Report More
Select for export From prohibited to prescribed: The rescheduling of MDMA and psilocybin in Australia No abstract availability was recorded for this entry. Details DOI 10.1177/20503245231198472 Copy citation Copy BibTeX Drug Science Policy and Law 2022-12-31 Octavian Dixon Ritchie, Cameron N Donley, Gabrielle Dixon Ritchie OpenAlex Published psilocybin Toxicity Other More
Select for export Psychedelic-induced mystical experiences: An interdisciplinary discussion and critique. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2023.1077311 PubMed 37181886 Copy citation Copy BibTeX Frontiers in psychiatry 2022-12-31 Mosurinjohn S, Roseman L, Girn M PubMed Published psilocybin Mystical Experience Other More
Psilocybin-Research.com
Searchable psilocybin and psilocin bibliometric database.